
Beyond immune support: Current trends in sports nutrition
As consumers reconfigure their life and nutrition choices, brands are also adapting to not only to stay relevant, but to survive.

As consumers reconfigure their life and nutrition choices, brands are also adapting to not only to stay relevant, but to survive.

Whether it's probiotic chews or oral immune spray, delivery systems are getting convenient and creative this summer.

Vitamin K2 has vital functions beyond vitamin K1 and should be considered for its own RDI, researchers argued in a review paper published recently.

The bioactivity of commercial bovine colostrum samples may vary significantly, says a new study partially funded by colostrum-based nutrition company, PanTheryx, which the company says aims to shine a spotlight on sourcing and handling.

There is no evidence to support taking vitamin D supplements to specifically prevent or treat COVID‑19 but everyone should consider taking vitamin D supplements if they are in lockdown, the UK government has announced.

A daily probiotic drink (Lactobacillus Casei) may have the potential to modulate anxiety and enhance training in football players, according to a new randomised, double-blinded, placebo-controlled trial.

Researchers say a new review reveals that probiotics, prebiotics and synbiotics exhibit potential to treat non-alcoholic fatty liver disease (NAFLD) by targeting the gut microbiota.

There is huge scope in tailoring active and sports nutrition products toward the general population, especially if the can also offer immunity benefits, an expert panel has underlined.

Join experts from Coca Cola Amatil’s investment arm, China specialists Bits x Bites, Middle East dairy pioneers Koita Foods and Australian vegan chocolate start-up Bite Society in our free webinar on Wednesday (July 1).

Singapore firm ONI Global, a franchisee of GNC, has reported ‘solid growth’ for its performance this year and made clear its intention to expand its brick-and-mortar presence – despite the financial woes being faced by the global retailer in the US.

BY-HEALTH is aiming to raise RMB$3.6bn (US$509m) to fund five new projects, including new manufacturing sites in China and Australia, and a health management centre.